Want to see ETST full AI Analyst Report?
Top Page
Earth Science Tech
(OTC:ETST)
Select Model
Select Model
Rating:60Neutral
Price Target:
$0.09
▼(-5.56% Downside)
Action:Reiterated
Date:10/13/26
The score is primarily supported by improved financial footing (strong margins, profitability, and a very low-debt balance sheet) and a low P/E valuation, but it is held back by a pronounced technical downtrend and the fundamental risk signaled by the sharp TTM revenue decline. Positive corporate actions and acquisitions add support, but the trend and growth uncertainty limit the overall rating.
Positive Factors
Healthy profitability
Strong gross and net margins indicate that ETST is currently retaining meaningful value from its operations rather than relying solely on revenue expansion. If these margins remain durable, they can support reinvestment, strengthen resilience, and provide a foundation for improving earnings over the next several quarters.
Negative Factors
Revenue contraction
The sharp TTM revenue decline raises questions about demand durability and whether ETST can consistently scale its products and services. Even with healthy current margins, continued top-line weakness could reduce operating leverage, constrain reinvestment, and make recent profitability harder to sustain.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy profitability
Strong gross and net margins indicate that ETST is currently retaining meaningful value from its operations rather than relying solely on revenue expansion. If these margins remain durable, they can support reinvestment, strengthen resilience, and provide a foundation for improving earnings over the next several quarters.
Read all positive factors
Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$23.42M
Dividend YieldN/A
Average Volume (3M)57.94K
Price to Earnings (P/E)6.4
Beta (1Y)2.18
Revenue Growth7.96%
EPS Growth51.14%
CountryUS
Employees77
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)0.01
Shares Outstanding287,590,880
10 Day Avg. Volume6,617
30 Day Avg. Volume57,940
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)3.71
Price to Sales (P/S)0.73
P/FCF Ratio21.98
Enterprise Value/Market Cap2.00
Enterprise Value/Revenue1.30
Enterprise Value/Gross Profit2.42
Enterprise Value/Ebitda9.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)$42.99M
Earth Science Tech Business Overview & Revenue Model
Company Description
Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, ...
Earth Science Tech Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
67
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Jun 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.96M | 35.70M | 33.12M | 11.95M | 48.54K | 14.12K |
| Gross Profit | 19.34M | 25.49M | 24.30M | 7.83M | 22.06K | -8.52K |
| EBITDA | 4.94M | 3.39M | 3.54M | 1.47M | -382.19K | -219.21K |
| Net Income | 3.89M | 3.63M | 3.25M | 812.14K | -365.40K | 3.17M |
Balance Sheet | ||||||
| Total Assets | 10.37M | 8.97M | 7.07M | 3.88M | 2.73M | 76.94K |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 2.16M | 2.12M | 697.72K | 35.76K | 26.94K |
| Total Debt | 353.16K | 96.21K | 401.24K | 246.59K | 974.11K | 780.69K |
| Total Liabilities | 3.01M | 1.93M | 3.22M | 1.63M | 1.61M | 1.88M |
| Stockholders Equity | 7.34M | 7.01M | 3.85M | 2.25M | 1.12M | -1.81M |
Cash Flow | ||||||
| Free Cash Flow | 1.74M | 1.18M | 3.62M | 1.18M | -1.01M | -166.39K |
| Operating Cash Flow | 2.31M | 1.94M | 4.37M | 1.21M | -1.01M | -168.11K |
| Investing Cash Flow | -1.72M | -1.90M | -1.88M | -26.52K | 0.00 | 1.71K |
| Financing Cash Flow | -838.30K | -712.92K | -1.72M | -517.88K | 1.02M | 173.18K |
Earth Science Tech Technical Analysis
Negative
0.09
Price Trends
0.09
Negative
0.12
Negative
0.13
Negative
Market Momentum
>-0.01
Positive
27.64
Positive
-9.72
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.09, below the 50-day MA of 0.09, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 27.64 is Positive, neither overbought nor oversold. The STOCH value of -9.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.
Earth Science Tech Risk Analysis
Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Earth Science Tech Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $23.42M | 6.41 | 62.03% | ― | 7.96% | 51.14% | |
57 Neutral | $30.51M | -5.65 | -14.03% | ― | -21.12% | -109.07% | |
52 Neutral | $56.06M | -3.35 | -87.28% | ― | -96.30% | 35.57% | |
52 Neutral | $40.10M | -2.17 | -21.10% | ― | 489.78% | 45.39% | |
52 Neutral | $104.88M | -10.04 | -47.10% | 19.33% | -25.68% | -244.92% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $35.18M | -0.58 | -118.89% | ― | 33.82% | 34.05% |
* Healthcare Sector Average
ETST
Earth Science Tech
0.09
-0.08
-46.88%
TLPH
Talphera
1.07
-0.07
-6.14%
RMTI
Rockwell Med
7.85
-4.15
-34.58%
SCYX
SCYNEXIS
3.99
-2.51
-38.61%
CPIX
Cumberland Pharmaceuticals
7.17
4.55
173.56%
COSM
Cosmos Holdings
0.38
-0.71
-65.11%
Earth Science Tech Corporate Events
Business Operations and StrategyExecutive/Board ChangesDelistings and Listing ChangesShareholder MeetingsStock Split
Earth Science Tech Shareholders Back Governance and Uplisting Plan
Positive
Sep 1, 2026
Earth Science Tech, Inc. held its first annual meeting of stockholders virtually on August 31, 2026, where shareholders re-elected all seven directors and ratified Semple, Marchal Cooper, LLP as the independent registered public accounting firm f...
Business Operations and StrategyM&A Transactions
Earth Science Tech Acquires Zoolzy to Expand Healthcare Operations
Positive
Aug 19, 2026
On August 19, 2026, Earth Science Tech, Inc. announced it had acquired Zoolzy LLC, a Doral, Florida-based wholesale distributor of active pharmaceutical ingredients and finished FDA-approved prescription products operating from a 3,684-square-foot...
Business Operations and StrategyM&A Transactions
Earth Science Tech Expands Footprint With Meduvo Acquisition
Positive
Aug 12, 2026
On August 11, 2026, Earth Science Tech, Inc. entered into an agreement to acquire Meduvo LLC, a compounding pharmacy based in La Verne, California, in a transaction deemed immaterial in size. The deal was structured as a related-party transaction ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.